AGL 38.39 Increased By ▲ 0.17 (0.44%)
AIRLINK 129.09 Increased By ▲ 0.12 (0.09%)
BOP 8.68 Increased By ▲ 0.83 (10.57%)
CNERGY 4.76 Increased By ▲ 0.10 (2.15%)
DCL 8.62 Increased By ▲ 0.30 (3.61%)
DFML 38.60 Decreased By ▼ -0.34 (-0.87%)
DGKC 84.50 Increased By ▲ 2.56 (3.12%)
FCCL 34.71 Increased By ▲ 1.29 (3.86%)
FFBL 76.75 Increased By ▲ 1.04 (1.37%)
FFL 12.80 Decreased By ▼ -0.02 (-0.16%)
HUBC 110.40 Increased By ▲ 0.04 (0.04%)
HUMNL 14.50 Increased By ▲ 0.49 (3.5%)
KEL 5.42 Increased By ▲ 0.27 (5.24%)
KOSM 7.77 Increased By ▲ 0.10 (1.3%)
MLCF 40.80 Increased By ▲ 1.00 (2.51%)
NBP 69.60 Decreased By ▼ -2.72 (-3.76%)
OGDC 190.75 Increased By ▲ 2.46 (1.31%)
PAEL 26.10 Increased By ▲ 0.47 (1.83%)
PIBTL 7.48 Increased By ▲ 0.11 (1.49%)
PPL 156.51 Increased By ▲ 3.84 (2.52%)
PRL 25.68 Increased By ▲ 0.29 (1.14%)
PTC 18.70 Increased By ▲ 1.00 (5.65%)
SEARL 82.88 Increased By ▲ 0.46 (0.56%)
TELE 7.85 Increased By ▲ 0.26 (3.43%)
TOMCL 32.80 Increased By ▲ 0.23 (0.71%)
TPLP 8.38 Decreased By ▼ -0.04 (-0.48%)
TREET 17.15 Increased By ▲ 0.37 (2.21%)
TRG 56.01 Decreased By ▼ -0.03 (-0.05%)
UNITY 28.99 Increased By ▲ 0.21 (0.73%)
WTL 1.35 No Change ▼ 0.00 (0%)
BR100 10,716 Increased By 57.2 (0.54%)
BR30 31,765 Increased By 433.6 (1.38%)
KSE100 99,706 Increased By 437 (0.44%)
KSE30 31,071 Increased By 39.1 (0.13%)

OCCUPIED JERUSALEM: Fourth doses of the Pfizer and Moderna vaccines against Covid-19 are only “partially” effective for the Omicron variant of the virus, the authors of an Israeli trial said Monday.

A team from Sheba Medical Center near Tel Aviv began conducting a trial in December on fourth doses of coronavirus vaccines, inoculating 154 hospital personnel with Pfizer jabs and 120 other volunteers with Moderna doses.

Preliminary results of the trial “have shown that the vaccines are safe and have shown to produce substantial antibodies, but are only partially effective in defending against the Omicron variant,” the hospital said in a statement.

Professor Gili Regev-Yochay, who leads the study, said that while there was an increase in antibodies after administering a fourth dose, it nonetheless “only offers a partial defenser against the virus” for those infected with the Omicron variant.

The vaccines were “extremely effective against the earlier variants,” Regev-Yochay noted. Israel was among the first countries to launch mass immunisation campaigns for its population.

It then began offering booster shots last summer, and has since greenlighted fourth shots for elderly and vulnerable populations. More than 537,000 Israelis have received a fourth dose of vaccine, according to the health ministry’s latest figures.

More than 80 percent of Israel’s adult residents have received two coronavirus vaccine shots and more than half have also been given a booster. Meanwhile, the Israeli government on Monday said it was reducing the quarantine period for positive cases from seven to five days, as a record number of infections threatens to overburden the economy.

“This decision will enable us to continue safeguarding public health on the one hand and to keep the economy going at this time on the other, even though it is difficult,” Prime Minister Naftali Bennett said in a short video message sent by his office.

Faced with skyrocketing infections fuelled by the Omicron variant, Israel has become the latest country to reduce quarantine periods, after similar moves from France, Spain, Argentina, the United States and Britain.

Israel shuttered its borders after discovering one case infected with the Omicron variant in November, but reopened in early January, despite a spike in infections.

In total, more than 1.7 million infections have been recorded since the start of the pandemic in Israel, including more than 8,300 deaths, according to official figures.

Comments

Comments are closed.